( is a major program ofthe National Cen...)First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America,Health

is a major program of the National Center for Health Statistics (NCHS), which is part of the Centers for Disease Control and Prevention (CDC). NHANES collects detailed medical information from roughly 5,000 people each year. For the report, the NHANES data are combined with economic information from the 2000, 2002 and 2004 Medical Expenditure Panel Survey (MEPS), which is cosponsored by the Agency for Healthcare Research and Quality and the NCHS. MEPS began in 1996 compiling detailed information on healthcare utilization and expenditures. Data has been collected by MEPS through 2004. Cost estimates in this report were adjusted for inflation to reflect 2006 costs. Adults over the age of 20 were included in the NHANES and MEPS analyses and no distinction could be made between type 1 and type 2 diabetes populations. However, because type 2 diabetes accounts for 90-95 percent of diagnosed diabetes cases, results from the NHANES and MEPS analyses include mostly people with type 2 diabetes. By examining both studies together, the State of Diabetes Complications in America report gives a comprehensive overview of the impact of diabetes-related complications in the U.S.

    (1) In the NHANES study, "chronic kidney disease" refers to people with

        microalbuminuria (albumim:creatinine ratio >30 ug/mg).


    (2) "Eye damage" includes a positive response by NHANES participants to

        the question, "Have you been told diabetes has affected your eyes/had

        retinopathy?"  Retinopathy is damage to the eye's retina.


    (3) Costs for kidney disease in MEPS do not include the institutionalized

        population.  Costs do include dialysis patients.


    (4) In the MEPS analysis, "foot problems" does not include costs for

        foot/toe amputations as these could not be identified in the MEPS

        public-use database.  Additionally, costs for prosthetics are not

        included.


    (5) In the MEPS economic analysis, "eye damage" includes
'"/>




Page: 1 2 3 4 5 6 7 
Related medicine technology :

1. Largest National U.S. Healthcare Facility MRSA Study Reveals
Infection Rates Eight Times Greater Than Previous Estimates
2. Actilyse (alteplase) Recommended by National Institute for Health
and Clinical Excellence for Treatment of Acute Ischaemic Stroke
3. Positive Results Prompt US National Cancer Institute to Make Glivec
Available to Patients in Post-Surgical GIST Study
4. Positive Results Prompt US National Cancer Institute to Make
Gleevec Available To Patients in Post-Surgical Gist Study
5. Research Results on FluMist Presented at National Association of
Pediatric Nurse Practitioners Conference
6. Protox Announces Publication in Journal of the National Cancer
Institute Supporting PRX302 as Treatment for Prostatic Diseases
7. Calando Pharmaceuticals Publishes the First Non-Human Primate Study
on Targeted, Systemic Delivery of siRNA in National Academy of
Sciences Journal
8. Advanced Magnetics Announces Presentation of Ferumoxytol Data at
the National Kidney Foundation 2007 Spring Clinical Meetings
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology
With Vascular Disease
10. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial
Targeting Systems Success in Mouse Model Reported in Cancer Cell
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal
Allergic Rhinitis